Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Alnylam Pharmaceuticals Inc. (ALNY) Insider Trading Activity
Healthcare • Biotechnology • 2,100 employees
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Total Value
-$21,763,701.21
Total Shares
70,714
Average Trade Value
-$104,633.18
Most Active Insider
Garg Pushkal
Total Activity: $21,893,176
Largest Single Transaction
$14,988,720
by Garg Pushkal on Jan 27, 2025
30-Day Activity
8 Transactions
Volume: 1,652 shares
Value: $398,298
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Cso Evp, Head of Research
Officer
|
Mar 4, 2025 | 71 | $17,248 | 13,501 (-0.5%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 4, 2025 | 343 | $82,636 | 24,860 (-1.4%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 4, 2025 | 121 | $28,948 | 14,224 (-0.9%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 4, 2025 | 328 | $79,032 | 13,896 (-2.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 4, 2025 | 120 | $29,124 | 24,542 (-0.5%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 4, 2025 | 198 | $47,837 | 24,662 (-0.8%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 4, 2025 | 324 | $78,304 | 13,572 (-2.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 4, 2025 | 147 | $35,170 | 25,203 (-0.6%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 3,871 | $10,000 | 16,256 (+23.8%) | Grant | |
|
Evp, Clo and Secretary
Officer
|
Mar 3, 2025 | 757 | $10,000 | 8,002 (+9.5%) | Grant | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 29 | $7,139 | 28,014 (-0.1%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 3 | $742 | 28,011 (-0.0%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 116 | $28,450 | 26,377 (-0.4%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 142 | $34,557 | 28,209 (-0.5%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 131 | $31,750 | 28,351 (-0.5%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 14,137 | $0 | 28,482 (+49.6%) | Grant | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 70 | $17,168 | 28,043 (-0.2%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Mar 3, 2025 | 96 | $23,463 | 28,113 (-0.3%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 4 | $993 | 98,635 (-0.0%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 23 | $5,689 | 98,639 (-0.0%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 5 | $1,237 | 26,324 (-0.0%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 580 | $142,251 | 98,900 (-0.6%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 238 | $58,591 | 98,662 (-0.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 791 | $193,328 | 99,480 (-0.8%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 1,173 | $285,461 | 100,271 (-1.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 1,068 | $258,851 | 101,444 (-1.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 17,965 | $0 | 102,512 (+17.5%) | Grant | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 117 | $28,727 | 25,350 (-0.5%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 273 | $66,729 | 25,467 (-1.1%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 213 | $51,625 | 26,886 (-0.8%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 1 | $248 | 26,323 (-0.0%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 158 | $38,617 | 26,493 (-0.6%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 583 | $141,745 | 25,740 (-2.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 48 | $11,817 | 26,329 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 189 | $46,354 | 47,836 (-0.4%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 15,117 | $0 | 49,015 (+30.8%) | Grant | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 258 | $63,058 | 48,025 (-0.5%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 77 | $18,956 | 47,759 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 7 | $1,731 | 47,752 (-0.0%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 1 | $248 | 47,751 (-0.0%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 350 | $84,830 | 48,665 (-0.7%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Mar 3, 2025 | 382 | $92,964 | 48,283 (-0.8%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 219 | $53,721 | 14,345 (-1.5%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 487 | $118,799 | 14,564 (-3.3%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 465 | $112,851 | 15,051 (-3.1%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 235 | $57,190 | 26,651 (-0.9%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 1 | $248 | 15,516 (-0.0%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 4 | $989 | 15,517 (-0.0%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 45 | $11,078 | 15,521 (-0.3%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 111 | $27,224 | 15,566 (-0.7%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Mar 3, 2025 | 14,137 | $0 | 27,099 (+52.2%) | Grant | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 151 | $36,906 | 15,677 (-1.0%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 224 | $54,513 | 15,828 (-1.4%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Mar 3, 2025 | 204 | $49,443 | 16,052 (-1.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 51 | $12,062 | 13,846 (-0.4%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 23 | $5,501 | 14,785 (-0.2%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 28 | $6,622 | 14,830 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 79 | $19,079 | 12,684 (-0.6%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 82 | $19,804 | 14,653 (-0.6%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 21 | $5,005 | 12,833 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 187 | $45,336 | 12,497 (-1.5%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 22 | $5,262 | 12,811 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 48 | $11,535 | 12,763 (-0.4%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 75 | $18,242 | 12,422 (-0.6%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 37 | $9,032 | 12,385 (-0.3%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 28, 2025 | 27 | $6,386 | 12,854 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 78 | $18,745 | 34,505 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 300 | $72,732 | 34,078 (-0.9%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 42 | $9,933 | 34,652 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 34 | $8,103 | 34,618 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 127 | $30,672 | 34,378 (-0.4%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 35 | $8,371 | 34,583 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 127 | $30,376 | 87,039 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 121 | $29,431 | 33,957 (-0.4%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 123 | $29,315 | 87,166 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 28, 2025 | 59 | $14,402 | 33,898 (-0.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 158 | $37,369 | 87,289 (-0.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 461 | $111,336 | 86,294 (-0.5%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 214 | $52,240 | 84,547 (-0.3%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 284 | $68,251 | 86,755 (-0.3%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 1,093 | $264,987 | 85,201 (-1.3%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 28, 2025 | 440 | $107,021 | 84,761 (-0.5%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 22 | $5,243 | 14,808 (-0.1%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 50 | $12,016 | 14,735 (-0.3%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 192 | $46,548 | 14,461 (-1.3%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 78 | $18,972 | 14,383 (-0.5%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 28, 2025 | 38 | $9,276 | 14,345 (-0.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 40 | $9,533 | 13,806 (-0.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 69 | $16,844 | 12,962 (-0.5%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 91 | $21,869 | 13,674 (-0.7%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 352 | $85,339 | 13,173 (-2.7%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 41 | $9,806 | 13,765 (-0.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 149 | $35,985 | 13,525 (-1.1%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 28, 2025 | 142 | $34,539 | 13,031 (-1.1%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 27, 2025 | 1,908 | $10,000 | 13,897 (+13.7%) | Exercise/Conversion | |
|
Chief Executive Officer
Director, Officer
|
Feb 27, 2025 | 5,921 | $10,000 | 87,447 (+6.8%) | Exercise/Conversion | |
|
Evp, Chief Financial Officer
Officer
|
Feb 27, 2025 | 1,908 | $10,000 | 34,694 (+5.5%) | Exercise/Conversion | |
|
Evp, Chief Commercial Officer
Officer
|
Feb 27, 2025 | 1,667 | $10,000 | 14,858 (+11.2%) | Exercise/Conversion | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 18, 2025 | 107 | $27,605 | 12,069 (-0.9%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 18, 2025 | 110 | $27,676 | 12,259 (-0.9%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 18, 2025 | 862 | $215,595 | 12,675 (-6.8%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 18, 2025 | 80 | $20,484 | 13,040 (-0.6%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 18, 2025 | 83 | $21,505 | 12,881 (-0.6%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 18, 2025 | 115 | $28,934 | 13,120 (-0.9%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 18, 2025 | 1,086 | $271,728 | 13,235 (-8.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 18, 2025 | 76 | $19,592 | 12,964 (-0.6%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 18, 2025 | 80 | $20,728 | 11,989 (-0.7%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 18, 2025 | 83 | $21,252 | 12,176 (-0.7%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 18, 2025 | 306 | $76,723 | 12,369 (-2.5%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 37 | $9,674 | 32,823 (-0.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 26 | $6,695 | 14,439 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 164 | $41,553 | 14,675 (-1.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 47 | $12,011 | 14,518 (-0.3%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 33 | $8,516 | 14,406 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 14 | $3,708 | 14,321 (-0.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 145 | $36,613 | 14,839 (-1.0%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 110 | $27,979 | 14,565 (-0.8%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 21 | $5,472 | 14,373 (-0.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 26 | $6,798 | 14,347 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 53 | $13,583 | 14,465 (-0.4%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 12 | $3,117 | 14,394 (-0.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 14, 2025 | 12 | $3,160 | 14,335 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 201 | $51,124 | 81,967 (-0.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 300 | $76,011 | 82,168 (-0.4%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 271 | $68,428 | 82,468 (-0.3%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 85 | $21,723 | 81,882 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 47 | $12,103 | 81,737 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 59 | $15,226 | 81,678 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 47 | $12,288 | 81,572 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 98 | $25,116 | 81,784 (-0.1%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 21 | $5,530 | 81,551 (-0.0%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 21 | $5,454 | 81,657 (-0.0%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 38 | $9,902 | 81,619 (-0.0%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Feb 14, 2025 | 25 | $6,622 | 81,526 (-0.0%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 258 | $65,622 | 14,105 (-1.8%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 386 | $97,801 | 14,363 (-2.7%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 349 | $88,123 | 14,749 (-2.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 110 | $28,112 | 13,995 (-0.8%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 77 | $19,871 | 13,732 (-0.6%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 60 | $15,687 | 13,596 (-0.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 126 | $32,293 | 13,869 (-0.9%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 60 | $15,451 | 13,809 (-0.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 27 | $7,012 | 13,705 (-0.2%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 49 | $12,768 | 13,656 (-0.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 27 | $7,110 | 13,569 (-0.2%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 14, 2025 | 32 | $8,476 | 13,537 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 78 | $19,991 | 32,991 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 217 | $54,793 | 33,536 (-0.6%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 239 | $60,555 | 33,297 (-0.7%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 160 | $40,696 | 33,137 (-0.5%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 30 | $7,817 | 32,860 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 20 | $5,297 | 32,786 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 68 | $17,378 | 33,069 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 37 | $9,528 | 32,954 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 17 | $4,415 | 32,890 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 47 | $12,129 | 32,907 (-0.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Feb 14, 2025 | 17 | $4,477 | 32,806 (-0.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Feb 13, 2025 | 2,103 | $0 | 14,984 (+14.0%) | Grant | |
|
Evp, Chief Financial Officer
Officer
|
Feb 13, 2025 | 3,109 | $0 | 33,753 (+9.2%) | Grant | |
|
Cmo EVP Dev Med Affairs
Officer
|
Feb 13, 2025 | 3,109 | $0 | 15,098 (+20.6%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Feb 13, 2025 | 3,859 | $0 | 82,739 (+4.7%) | Grant | |
|
Cmo EVP Dev Med Affairs
Officer
|
Jan 27, 2025 | 25,000 | $2,223,750 | 64,581 (+38.7%) | Exercise/Conversion | |
|
Cmo EVP Dev Med Affairs
Officer
|
Jan 27, 2025 | 23,876 | $2,123,770 | 39,581 (+60.3%) | Exercise/Conversion | |
|
Cmo EVP Dev Med Affairs
Officer
|
Jan 27, 2025 | 52,592 | $14,988,720 | 11,989 (-438.7%) | Sale | |
|
Director
|
Jan 23, 2025 | 11,250 | $1,476,113 | 11,250 (+100.0%) | Exercise/Conversion | |
|
Director
|
Jan 23, 2025 | 11,250 | $3,093,750 | 0 | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 186 | $46,312 | 17,150 (-1.1%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 1 | $256 | 15,705 (-0.0%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 426 | $106,534 | 16,724 (-2.5%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 140 | $35,612 | 15,706 (-0.9%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 778 | $195,807 | 15,946 (-4.9%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 100 | $25,294 | 15,846 (-0.6%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Dec 12, 2024 | 121 | $29,945 | 17,336 (-0.7%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 27, 2024 | 360 | $91,238 | 12,991 (-2.8%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 27, 2024 | 110 | $27,993 | 12,881 (-0.9%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 27, 2024 | 210 | $52,595 | 14,202 (-1.5%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 27, 2024 | 851 | $214,435 | 13,351 (-6.4%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Nov 26, 2024 | 97 | $24,470 | 30,644 (-0.3%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Nov 26, 2024 | 364 | $91,248 | 31,686 (-1.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Nov 26, 2024 | 30 | $7,433 | 32,296 (-0.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 26, 2024 | 826 | $207,673 | 14,496 (-5.7%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 26, 2024 | 318 | $79,716 | 15,322 (-2.1%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 26, 2024 | 215 | $53,664 | 15,640 (-1.4%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 26, 2024 | 26 | $6,442 | 15,855 (-0.2%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Nov 26, 2024 | 945 | $237,592 | 30,741 (-3.1%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Nov 26, 2024 | 246 | $61,402 | 32,050 (-0.8%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Nov 26, 2024 | 84 | $21,191 | 13,191 (-0.6%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 26, 2024 | 300 | $75,681 | 78,880 (-0.4%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Nov 26, 2024 | 215 | $53,664 | 14,419 (-1.5%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 26, 2024 | 762 | $190,195 | 83,244 (-0.9%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Nov 26, 2024 | 26 | $6,442 | 14,634 (-0.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 26, 2024 | 93 | $23,043 | 84,006 (-0.1%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Nov 26, 2024 | 826 | $207,673 | 13,275 (-6.2%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 26, 2024 | 2,933 | $737,415 | 79,180 (-3.7%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Nov 26, 2024 | 1,131 | $283,519 | 82,113 (-1.4%) | Sale | |
|
Evp, Chief Commercial Officer
Officer
|
Nov 26, 2024 | 318 | $79,716 | 14,101 (-2.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Nov 26, 2024 | 945 | $237,592 | 17,554 (-5.4%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Nov 26, 2024 | 246 | $61,402 | 18,863 (-1.3%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Nov 26, 2024 | 97 | $24,470 | 17,457 (-0.6%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Nov 26, 2024 | 30 | $7,433 | 19,109 (-0.2%) | Sale | |
|
Cso Evp, Head of Research
Officer
|
Nov 26, 2024 | 84 | $21,191 | 14,412 (-0.6%) | Sale | |
|
Cmo EVP Dev Med Affairs
Officer
|
Nov 26, 2024 | 364 | $91,248 | 18,499 (-2.0%) | Sale | |
|
Evp, Chief Financial Officer
Officer
|
Nov 25, 2024 | 3,434 | $0 | 32,326 (+10.6%) | Grant | |
|
Cmo EVP Dev Med Affairs
Officer
|
Nov 25, 2024 | 3,434 | $0 | 19,139 (+17.9%) | Grant | |
|
Cso Evp, Head of Research
Officer
|
Nov 25, 2024 | 3,000 | $0 | 15,881 (+18.9%) | Grant | |
|
Evp, Chief Commercial Officer
Officer
|
Nov 25, 2024 | 3,000 | $0 | 14,660 (+20.5%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Nov 25, 2024 | 10,658 | $0 | 84,099 (+12.7%) | Grant | |
|
Cmo EVP Dev Med Affairs
Officer
|
Oct 8, 2024 | 96 | $50,000 | 15,705 (+0.6%) | Grant |